Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres. Br J Haematol 2011;153:358-63.Stephen D., SmithCraig H., MoskowitzRobert, DeanBrad, PohlmanRonald, SobecksEdward, CopelanSteven, AndresenBrian, BolwellJocelyn C., MaraguliaJill M...
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marr... PURPOSE: To evaluate the results of high-dose chemotherapy and autologous hematopoietic stem-cell transplantation (autotransplants) in patients ...
Given the relatively limited data supporting a graft-versus-lymphoma (GVL) effect in Hodgkin's disease, second autologous transplant may be a more attractive option than non-myeloablative allogeneic transplant. However, non-myeloablative sibling donor transplants may be preferable for patients who ...
Multiple myeloma accounted for 11% of patients aged ≥ 60 and 18% of younger patients. Other diseases included chronic lymphocytic leukemia (n = 2 vs. 0), chronic myelogenous leukemia (n = 1 vs. 9), myeloproliferative disease (n = 5 vs. 4), non-Hodgkin lymphoma (n...
several investigations have demonstrated that KIR haplotypes predict the prognosis and the conversion of MDS to AML47; the incidence of leukemia48and solid tumors49; the prognosis of classical Hodgkin’s lymphoma50; the prognosis and response to targeted therapies in colorectal cancer51,52; and the...
Immune consolidation after stem cell transplant for CD20+ nonhodgkin's lymphoma using multiple infusions of autologous activated t cells (ATC) with anti-cd3 x anti-cd20 bispecific antibody (CD20Bi) to improve graft-vs-lymphoma effects 来自 Elsevier 喜欢 0 阅读量: 31 作者:...
Diffuse large B cell lymphoma (DLBCL) is the most common form of aggressive non-Hodgkin lymphoma (NHL). The probability of being cured by the initial treatment is predicted by the International Prognostic Index (IPI), which accounts for age, performance status, tumor stage, lactate dehydrogenase...
It has been shown recently that allogeneic haematopoietic stem cell transplantation (HSCT) can be considered as a clinical option in the treatment of refractory and relapsed Hodgkin's disease. However, potent T-cell immuno-suppression predisposes to the development of post-transplant lymphoproliferative ...
Non-Hodgkin lymphoma Leukemia Kidney Renal Bladder Brain Ovarian Liver Lung Colorectal Cervical Breast Prostate Many health practitioners recommend taking 500-1000 mg doses, 3-4 times daily with food. Curcumin should also be mixed with piperine from black pepper and taken with a fat-based meal fo...
A 56-year-old woman with Hodgkin-like adult T-cell leukemia/lymphoma was treated with allogeneic peripheral blood stem cell transplantation on 17 April 2009. She manifested a moderate fever on day 4 CT scanning and other examinations detected slightly swollen lymph nodes, and pathological findings ...